-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Author . . . At present, there are more than 16.6 million confirmed cases of COVID-19 worldwide, more than 650,000 deaths, and a significant increase in both newly confirmed and fatal cases.
.S. has accumulated more than 4.34 million cases and nearly 150,000 deaths.
, which showed signs of abating, has worsened sharply again since the weekend.
cases have risen sharply or relapsed in several countries around the world, the United Nations and the World Health Organization are deeply concerned about the intensification of the outbreak, and many governments have announced the restoration of full or partial closures.
Conscioned thinking, generally mild patients need not worry too much, throughout the COVID-19 pandemic, most people believe that those with "minor illnesses" and those who do not need to stay in the ICU or use a ventilator are immune to serious adverse health consequences, and even some countries think that half of the confirmed CASE-19 cases are mild patients is a "good thing". After 2-3 weeks in
35% of patients with mild illness and still suffering from viral symptoms, a new study published recently in the U.S. Centers for Disease Control and Prevention's COVID-19 Morbidity and Mortality Weekly Report found that COVID-19 was not easy to get rid of even in patients with milder conditions.
Photo Source: Morbidityand Mortality WeeklyReport (MMWR) In a telephone survey involving multiple U.S. states, DR. Mark W. Tenforde of the CDC COVID-19 Emergency Response Team and colleagues conducted random telephone calls back 2-3 weeks after testing positive for the first CoV-2RT-PCR test for adult outpatient mild illness patients.
The survey found that 65 per cent of the 274 patients in the clinic had returned to health, with a median of seven days from the date of testing to the time they returned to health, and 35 per cent who had not yet returned to normal health in an interview.
of these mild outpatients, the most common symptoms reported were fatigue (71 per cent), cough (61 per cent) and headache (61 per cent).
called back, most patients had a fever and chill that had eased, while the most difficult symptoms to relieve were cough (43 percent did not relieve) and fatigue (35 percent did not).
26 (29%) of the 90 patients who reported shortness of breath at the time of the test were still present.
reported at the time of the test, and among the symptoms that had been alleviated prior to the interview, loss of smell and loss of taste lasted the longest time (median of 8 days).
that is, 35% of patients with mild illness, after 2-3 weeks, are still suffering from fatigue, cough, shortness of breath and other symptoms of the new coronary virus.
reasons for this, the CDCCOVID-19 Emergency Response Team did a statistical analysis and found that there was an age difference among those who did not return to normal health: 26%, 32% and 47% of those aged 18-34, 35-49 and older were not.
In addition, chronic diseases can also affect healthy recovery: there is no or only one chronic disease, there are two chronic diseases and there are three or more chronic diseases, the probability of not returning to normal health is 28%, 46% and 57%, respectively.
, 19 percent of 18-34-year-olds without chronic diseases did not return to normal health for unknown reasons.
Discussion Generally, more than 90 percent of influenza outpatients recover within about 2 weeks of testing positive, and for most people, COVID-19 "minor" is defined as a non-hospitalization at all, just a small flu treated with a two-week home break, but the report makes it clear that even "minor" outpatients are more complex, more dangerous, and harder to get rid of than many initially thought.
the author's point of view, the current concept of "light illness" has wrongly guided the public.
first, "mild" patients themselves are unable to seriously take relevance information into account when determining the level of risk;
Although China's epidemic has passed the Wuhan model of the great outbreak period, but the local outbreak is still repeated, from Beijing, Urumqi to Dalian, the emergence of a new crown outbreak has disrupted the lives of many people.
This report is important for understanding the characteristics of COVID-19, and we should still strongly encourage the public to take preventive measures, including maintaining social distance, washing hands frequently, and using masks properly in public places to reduce the spread of SARS-CoV-2."
source Morbidity Mortal and Weekly Report (MMWR) COVID-19 Can Results in Prolonged Chambers Even In Milder Cases.